Predictive Factors for Early Progression During Induction Chemotherapy and Chemotherapy-Free Interval: Analysis From PRODIGE 9 Trial

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-020-0735-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Risk Factors and the Prevention of Weight Gain During Induction Chemotherapy in Children With Acute Lymphoblastic Leukemia

Journal of Pediatric Hematology/Oncology
Child HealthOncologyPediatricsHematologyPerinatology
2018English

Neoadjuvant, Adjuvant and Long-Term Intravenous/Intraperitoneal Chemotherapy, Hyperthermic Intraperitoneal Chemotherapy, Early Postoperative Intraperitoneal Chemotherapy for Ovarian Cancer

Journal of Peritoneum (and other serosal surfaces)
2017English

VATS Pneumonectomy After Induction Chemotherapy

Journal of Clinical and Analytical Medicine
Medicine
2016English

Adjuvant Chemotherapy for Early Breast Cancer.

BMJ
1983English

Induction Chemotherapy, Chemoradiotherapy and Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer - Long-Term Results of Phase II OIGIT-01 Trial

Radiology and Oncology
Nuclear MedicineRadiologyImagingOncology
2018English

The Predictive Value of the 70-Gene Signature for Adjuvant Chemotherapy in Early Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

Elderly Do Benefit From Induction Chemotherapy: High Dose Mitoxantrone Based (“5+1”) Induction Chemotherapy Regimen in Newly Diagnosed Acute Myeloid Leukemia

American Journal of Hematology
Hematology
2018English

A Pairwise Meta‐Analysis of Induction Chemotherapy in Nasopharyngeal Carcinoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy